Gri Bio Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.86

+0.04 (+2.20%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 5 83%

Hold 1 17%

Sell 0 0%

Price Target

Analyst Price Target +2,017.7% upside

Low Target $26.66

Average Target $39.39

High Target $54.88

Current Price $1.86

Current
$1.86

Target
$39.39

$26.66 $39.39 avg $54.88

Scenario Analysis

Bear Case

$26.66

1,333.3%

Low target

Base Case

$39.39

+2,017.7%

Avg target

Bull Case

$54.88

+2,850.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$80.36

-97.7% from high

52-Week Low

$1.72

+8.1% from low

Target vs 52W High

$39.39

-51.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+1.3%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.1%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-12.3%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.1%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.5%